PHOTODYNAMIC THERAPY OF TYPICAL AND ATYPICAL KERATOACANTHOMA
- Authors: Molochkova Y.V.1,2, Kuntsevich Z.S.1,2, Sukhova T.E.1,2, Dibirova S.D.1,3,4, Galkin V.N.5,6, Ivanov S.A.5,6, Romanko Y.S.7,8,6
-
Affiliations:
- Moscow Regional Research and Clinical Institute (MONIKI)
- 61/2 Shchepkina ul., Moscow, 129110, Russian Federation
- 61/2 Shchepkina ul., Moscow, 129110, Russian Federation I.M. Sechenov First Moscow State Medical University
- 8/2 Trubetskaya ul., Moscow, 119991, Russian Federation
- A. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
- 10 Zhukova ul., Obninsk, Kaluzhskaya oblast', 249036, Russian Federation
- I.M. Sechenov First Moscow State Medical University
- 8/2 Trubetskaya ul., Moscow, 119991, Russian Federation A. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
- Issue: Vol 44, No 1 (2016)
- Pages: 64-70
- Section: DERMATO-ONCOLOGY
- URL: https://almclinmed.ru/jour/article/view/309
- DOI: https://doi.org/10.18786/2072-0505-2016-44-1-64-70
- ID: 309
Cite item
Full Text
Abstract
Background: Photodynamic therapy (PDT) has shown its clinical efcacy in the treatment of keratoacanthoma. However, the published data is scarce and contradictory. Methods of a photosensitizer administration and irradiation doses depending on the type of keratoacanthoma have not been defned. Aim: To develop the diferentiated approached to PDT for typical and atypical keratoacanthoma by variation of the light density while using of a chlorine photosensitizer. Materials and methods: We assessed and treated 36 patients with cytologically and/or histologically confrmed solitary keratoacanthomas, among them 22 patients with typical and 14 patients with atypical ones. In 12 patients, persistent keratoacanthomas were diagnosed, in 1, a gigantic one and in 1, a centripetal one. Each patient was administered one session of PDT with an intralesional administration of a photosensitizer Radachlorin at a dose of 0.75 mL/cm3. The source of laser irradiation was a medical laser device LAMI (with the wave- length of 662 ± 3 nm, the power of irradiation at the edge of the light guide, 2 Wt). The absorbed light density was 50 J/cm2 for typical keratoacanthomas and 300 J/cm2 for atypical ones. 70 Results: After the treatment, in 32 (89%) of patients the tumor completely regressed within one month (26 ± 1.3 days). In 4 patients (all with atypical keratoacanthomas) the tumors did not regress within one month and was removed surgically with the 3 mm margins of obviously normal skin. At the site of former tumors, there were areas of atrophic scarring (26 cases, in 4 patients, with hyperpigmentation) or with normotrophic scarring (10 patients) that were cosmetically acceptable. Within the next 2 years of the follow-up no relapses were observed. Conclusion: Thus, we proposed an efective method of diferentiated approach to PDT of typical and atypical keratoacanthomas based on one PDT session with an intralesional administration of Radachlorin at a dose of 0.75 mg/cm3 of the tumor, with the intensity of irradiation of 0.39 Wt/cm2. The light dose density for typical keratoacanthomas is 50 J/cm2 and for atypical ones, 300 J/cm2.
About the authors
Yu. V. Molochkova
Moscow Regional Research and Clinical Institute(MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation
Author for correspondence.
Email: yulia-molochkova@yandex.ru
MD, PhD, Senior Research Fellow, Dermatovenereology and Dermato-oncology Department Россия
Zh. S. Kuntsevich
Moscow Regional Research and Clinical Institute(MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation
Email: yulia-molochkova@yandex.ru
MD, PhD, Associate Profes- sor, Chair of Dermatovenereology and Dermato- oncology, Postgraduate Training Faculty
РоссияT. E. Sukhova
Moscow Regional Research and Clinical Institute(MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation
Email: yulia-molochkova@yandex.ru
MD, PhD, Senior Research Fellow, Dermatovenereology and Dermato-oncology Department Россия
S. D. Dibirova
Moscow Regional Research and Clinical Institute(MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation
I.M. Sechenov First Moscow State Medical University; 8/2 Trubetskaya ul., Moscow, 119991, Russian Federation
Email: yulia-molochkova@yandex.ru
MD, PhD student, Chair of Skin and Venereal Diseases, Institute for Professional Education Россия
V. N. Galkin
A. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; 10 Zhukova ul., Obninsk, Kaluzhskaya oblast', 249036, Russian Federation
Email: yulia-molochkova@yandex.ru
MD, PhD, Professor, Director
РоссияS. A. Ivanov
A. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; 10 Zhukova ul., Obninsk, Kaluzhskaya oblast', 249036, Russian Federation
Email: yulia-molochkova@yandex.ru
MD, PhD, Deputy Director on Science and Medicine Россия
Yu. S. Romanko
I.M. Sechenov First Moscow State Medical University; 8/2 Trubetskaya ul., Moscow, 119991, Russian FederationA. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; 10 Zhukova ul., Obninsk, Kaluzhskaya oblast', 249036, Russian Federation
Email: yulia-molochkova@yandex.ru
MD, PhD, Professor, Chair of On- cology and Radiotherapy, Institute for Professional Education, Head of Administration and Planning Division Россия
References
- Голдман МП, ред. Фотодинамическая терапия. Пер. с англ. М.: Рид Элсивер, Практическая Медицина; 2010. 196 с.
- Каплан МА, Капинус ВН, Попучиев ВВ, Романко ЮС, Ярославцева-Исаева ЕВ, Спиченкова ИС, Шубина АМ, Боргуль ОВ, Горанская ЕВ. Фотодинамическая терапия: результаты и перспективы. Радиация и риск. 2013;22(3):115–23.
- Zeitouni NC, Oserof A, Najarian DJ. Photodynamic therapy. In: MacFarlane DF, editor. Skin cancer management: a practical approach. New York: Springer; 2010. p. 41–56. doi: 10.1007/978-0-387-88495-04.
- Stranadko EPh, Titova VA, Riabov MV, Petrovski VYu. Photodynamic therapy as an optimal technique for treating lower lip cancer. Photodynamic therapy and photodiagnosis. 2010;7(Suppl I):18.
- Giomi B, Pagnini F, Cappuccini A, Bianchi B, Tiradritti L, Zuccati G. Immunological activity of photodynamic therapy for genital warts. Br J Dermatol. 2011;164(2):448–51. doi: 10.1111/j.1365-2133.2010.10089.x.
- Souza CS, Felício LB, Arruda D, Ferreira J, Kurachi C, Bagnato VS. Systemic photodynamic therapy as an option for keratoacanthoma centrifugum marginatum treatment. J Eur Acad Dermatol Venereol. 2009;23(1):101–2. doi: 10.1111/j.1468-3083.2008.02744.x.
- Radakovic-Fijan S, Hönigsmann H, Tanew A. Effcacy of topical photodynamic therapy of a gi- ant keratoacanthoma demonstrated by partial irradiation. Br J Dermatol. 1999;141(5):936–8. doi: 10.1046/j.1365-2133.1999.03180.x.
- Молочков ВА, Ильин ИИ, Беренбейн БА, Долгушин ИИ, Коган МГ. Кератоакантома. Свердловск: Уральский университет; 1991. 124 с.
- van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology. 2003;207(2):105–13. doi: 10.1078/0171-2985-00221.
- Hayami J, Okamoto H, Sugihara A, Horio T. Immunosuppressive efects of photodynamic therapy by topical aminolevulinic acid. J Der- matol. 2007;34(5):320–7. doi: 10.1111/j.1346-8138.2007.00280.x.
- Qiang YG, Yow CM, Huang Z. Combination of photodynamic therapy and immunomodulation: current status and future trends. Med Res Rev. 2008;28(4):632–44. doi: 10.1002/med.20121.
- Morton CA, McKenna KE, Rhodes LE; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159(6):1245–66. doi: 10.1111/j.1365-2133.2008.08882.x.
- Ferenczy A, Mitao M, Nagai N, Silverstein SJ, Crum CP. Latent papillomavirus and recurring genital warts. N Engl J Med. 1985;313(13):784–8. doi: 10.1056/NEJM198509263131304.
- Yan J, Chen SL, Wang HN, Wu TX. Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata. Dermatology. 2006;213(3):218–23. doi: 10.1159/000095039.
- Молочков ВА, Казанцева ИА, Кунцевич ЖС, Бочкарева ЕВ. Кератоакантома. Клиника, диагностика, лечение, трансформация в рак. М.: БИНОМ; 2006. 176 с.
- Lowes MA, Bishop GA, Cooke BE, Barnetson RS, Halliday GM. Keratoacanthomas have an immunosuppressive cytokine environment of increased IL-10 and decreased GM-CSF compared to squamous cell carcinomas. Br J Cancer. 1999;80(10):1501–5. doi: 10.1038/sj.bjc.6690552.
- Jacobsson S, Linell F, Rausing A. Florid keratoacanthomas in a kidney transplant recipient. Case report. Scand J Plast Reconstr Surg. 1974;8(3):243–6.
- Blitstein-Willinger E, Haas N, Nürnberger F, Stüttgen G. Immunological fndings during treatment of multiple keratoacanthoma with etretinate. Br J Dermatol. 1986;114(1):109–16. doi: 10.1111/j.1365-2133.1986.tb02785.x.
- Claudy A, Thivolet J. Multiple keratoacantho- mas: association with defcient cell mediated immunity. Br J Dermatol. 1975;93(5):593–5. doi: 10.1111/j.1365-2133.1975.tb02255.x.